Emerging Dermatologic Issues in the Oncology Patient

Seminars in Cutaneous Medicine and Surgery

Volumn 25, Issue 4, 2006, Pages 179-189

  Mays, Steven R ^a,b   Cohen, Philip R ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CETUXIMAB; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; VORICONAZOLE;

BASAL CELL CARCINOMA; CANCER PATIENT; CAUSE OF DEATH; CELLULITIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DEBRIDEMENT; DISEASE COURSE; DRUG EFFICACY; DRY SKIN; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; MOULD; MYCOSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; NONHUMAN; PUSTULE; REMISSION; REVIEW; SKIN CARCINOMA; SKIN DISEASE; SKIN INFECTION; SKIN MANIFESTATION; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; SYSTEMIC THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; SKIN DISEASES; SKIN NEOPLASMS;

EID: 33845425995     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2006.08.007     Document Type: Review

References (112)

1. Dignani M.C., and Anaissie E. Human fusariosis. Clin Microbiol Infect 10 suppl 1 (2004) 67-75
2. Nucci M., and Anaissie E. Cutaneous infection by Fusarium species in health and immunocompromised hosts: implication for diagnosis and management. Clin Infect Dis 35 (2002) 909-920
3. Torres H.A., Raad I., and Kontoyiannis D.P. Infections caused by Fusarium species. J Chemother 15 suppl 2 (2003) 28-35
4. Maertens J., Theunissen K., Verbeken E., et al. Prospective evaluation of lower cut-offs for Galactomannan detection in adult neutropenic cancer patients and hematological stem cell transplant recipients. Br J Hematol 26 (2004) 852-860
5. Mays S.R., Bogle M.A., and Bodey G.P. Cutaneous fungal infections in cancer patients: recognition and management. Am J Clin Dermatol 7 (2006) 31-43
6. Radhakrishnan R., Donato M.L., Prieto V.G., et al. Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy. J Surg Oncol 88 (2004) 21-26
7. Walmsley S., Devi S., King S., et al. Invasive aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis 12 (1993) 673-682
8. Bodey G.P., Boktour M., Mays S., et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 47 (2002) 659-666
9. Wolfson J.S., Sober A.J., and Rabin R.H. Dermatologic manifestations of infections in immunocompromised patients. Medicine 64 (1985) 115-133
10. Grossman M.E. Cutaneous Manifestations of Infection in the Immunocompromised Host (1995), Williams & Wilkins, Baltimore
11. All M.D., Miller J., Townsend T., et al. Primary cutaneous aspergillosis associated with hickman intravenous catheters. N Engl J Med 317 (1987) 1105-1108
12. McCarty J.M., Flam M.S., et al. Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. J Pediatr 108 (1986) 721-724
13. Singh N., and Paterson D.L. Aspergillus infections in transplant recipients. Clin Microbiol Rev 18 (2005) 44-69
14. Boutati E., and Anaissie E. Fusarium, a significant emerging pathogen in patients with hematologic malignancy. Blood (1997) 999-1008
15. Nucci M., Marr K.A., Queiroz-Telles F., et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 38 (2004) 1237-1242
16. Nucci M., and Marr K.A. Emerging fungal diseases. Clin Infect Dis 41 (2005) 521-526
17. Karthaus M., and Cornely O.A. Recent developments in the management of invasive fungal infections in patients with hematological malignancies. Ann Hematol 84 (2005) 207-216
18. Abbasi S., Shenep J.L., Hughes W.T., et al. Aspergillosis in children with cancer: a 34 year experience. Clin Infect Dis 29 (1999) 1210-1219
19. Klimowski L.L., Rotstein C., and Cummings K.M. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty year period. Infect Control Hosp Epidermiol 10 (1989) 299-305
20. Simoneau E., Killy M., Labbe A.C., et al. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients?. A 23 year experience. Bone Marrow Transpl 35 (2005) 303-306
21. Meyer P.D., Kaplan M.H., Ong M., et al. Cutaneous lesions in disseminated mucormycosis. J Am Med Assoc 225 (1973) 732-738
22. Myskowski P.L., Brown A.E., et al. Mucormycosis following bone marrow transplantation. J Am Acad Dermatol 9 (1983) 111-115
23. Kramer B.S., Hernendez A.D., Reddick R.L., et al. Cutaneous infarction: manifestation of disseminated mucormycosis. Arch Dermatol 113 (1977) 1075-1076
24. Kontoyiannis D.P., Lionakis M.S., Lewis R.E., et al. Zygomycosis in a tertiary care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191 (2005) 1350-1360
25. Baselga J., Rischin D., Ranson M., et al. Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol 20 (2002) 4292-4302
26. Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
27. Trigo J., Hitt R., Koralewski P., et al. Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): results of a phase II study (abstract 5022) [and slide presentation]. Proc Am Soc Clin Oncol 23 (2004) 487
28. Fukuoka M., Yano S., Giaccone G., et al. Multi-institutional randomized phase II trial of gefetinib for previously treated patients with advanced non-small-cell lung cancer. J Clin Oncol 21 (2003) 2237-2246
29. Hidalgo M., Siu L.L., Nemunaitis J., et al. Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J Clin Oncol 19 (2001) 3267-3279
30. Van Doorn R., Scheffer K.E., Stoof T.J., et al. Follicular and epidermal alterations in patients treated with Iressa, an inhibitor of the epidermal growth factor receptor. Br J Dermatol 147 (2002) 598
31. Lee M.W., Seo C.W., Kim S.W., et al. Cutaneous side effects in non-small cell lung cancer patients treated with Iressa, an inhibitor of epidermal growth factor. Acta Derm Venereol 84 (2004) 23-26
32. Fox L.P. Pathology and management of dermatologic toxicities associated with anti-EGFR therapy. Oncology (Williston Park) 20 suppl 2 (2006) 26-34
33. Busam K.J., Capodieci P., Motzer R., et al. Cutaneous side effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 144 (2001) 1169-1179
34. Nosari A., Orese P., Cairoli R., et al. Invasive aspergillosis in hematological malignancies: clinical findings and management for intensive chemotherapy conditioning. Am J Hematol 68 (2001) 231-236
35. Safadi R., Pappo O., Okon E., et al. Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leukemia Lymphoma 20 (1996) 509-511
36. Rashid K., Ng R., Mastan A., et al. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia. Leukemia Lymphoma 46 (2005) 1051-1055
37. Cottoni F., Montesu M.A., Lissia A., et al. Merkel cell carcinoma. Kaposi's sarcoma, basal cell carcinoma and keratoacanthoma: multiple association in a patient with chronic lymphocytic leukaemia. Br J Dermatol 147 (2002) 1029-1031 (letter)
38. Ramsay H.M., Fryer A., Strange R.C., et al. Multiple basal cell carcinomas in a patient with acute myeloid leukaemia and chronic lymphocytic leukaemia. Clin Exp Dermatol 24 (1999) 281-282
39. Klapman M.H. Cutaneous diseases preceding diagnoses of lymphoreticular malignancies. J Am Acad Dermatol 20 (1989) 583-586
40. Mehrany K., Weenig R.H., Pittelkow M.R., et al. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 140 (2004) 985-988
41. Mehrany K., Byrd D.R., Roenigk R.K., et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 29 (2003) 129-134
42. Friedman G.D., and Tekawa I.S. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 11 (2000) 891-897
43. Agnew K.L., Ruchlemer R., Catovsky D., et al. Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol 150 (2004) 1129-1135
44. Levi F., Randimbison L., Te V.-C., et al. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancer. Br J Cancer 74 (1996) 1847-1850
45. Dargent J.-L., Kornreich A., Andre L., et al. Cutaneous infiltrate of chronic lymphocytic leukemia surrounding a primary squamous cell carcinoma of the skin. Report of an additional case and reflection on its pathogenesis. J Cutan Pathol 25 (1998) 479-480 (letter)
46. Hartley B.E.J., Searle A.E., Breach N.M., et al. Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J Laryngol Otol 110 (1996) 694-695
47. Albregts T., Orengo I., Salasche S., et al. Squamous cell carcinoma in a patient with chronic lymphocytic leukemia. An intraoperative diagnostic challenge for the Mohs surgeon. Dermatol Surg 24 (1998) 269-272
48. Padgett J.K., Parlette III H.L., and English III J.C. A diagnosis of chronic lymphocytic leukemia prompted by cutaneous lymphocytic infiltrates present in Mohs micrographic surgery frozen sections. Dermatol Surg 29 (2003) 769-771
49. Davidovitz Y., Ballin A., and Meytes D. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia. Acta Haematol 98 (1997) 44-46
50. Frierson H.F., Deutsch B.D., and Levine P.A. Clinicopathologic features of squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma. Human Pathol 19 (1988) 1397-1402
51. Frierson Jr. H.F., Deutsch B.D., and Levine P.A. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Human Pathol 19 (1988) 1397-1402
52. Smith K.J., Germain M., and Skelton H. Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a COX inhibitor, Sulindac: potential applications for this combination of immunotherapy. Dermatol Surg 27 (2001) 143-146
53. Mehrany K., Weenig R.H., Pittelkow M.R., et al. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 31 (2005) 38-42
54. Adami J., Frisch M., Yuen J., et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 310 (1995) 1491-1495
55. Mehrany K., Weenig R.H., Lee K.K., et al. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 53 (2005) 1067-1071
56. Hull P.R., and Saxena A. Mycosis fungoides and chronic lymphocytic leukaemia-composite T-cell and B-cell lymphomas presenting in the skin. Br J Dermatol 143 (2000) 439-444
57. Grange F., Avril M.-F., Esteve E., et al. Coexistent cutaneous T-cell lymphoma with B-cell malignancy. J Am Acad Dermatol 31 (1994) 724-731
58. McKenna D.B., Doherty V.R., McLaren K.M., et al. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?. Br J Dermatol 143 (2000) 171-173
59. Carsuzaa F., Aubert L., Pierre C., et al. Malignant melanoma and hairy cell leukemia. Two cases. Nouv Rev Fr Hematol 34 (1992) 211-214
60. Travis L.B., Curtis R.E., Hankey B.F., et al. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 84 (1992) 1422-1427
61. Cahill R.A., McGreal G., Neary P., and Redmond H.P. Synchronous high-risk melanoma and lymphoid neoplasia. Melanoma Res 11 (2001) 517-522
62. McKenna D.B., Stockton D., Brewster D.H., et al. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 88 (2003) 74-78
63. Greene M.H., Hoover R.N., and Fraumeni J.F. Subsequent cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 61 (1978) 337-340
64. Sinclair N., Mireskandari K., Forbes J., et al. Merkel cell carcinoma of the eyelid in association with chronic lymphocytic leukaemia. Br J Ophthalmol 87 (2003) 240
65. Vlad R., and Woodlock T.J. Merkel cell carcinoma after chronic lymphocytic leukemia. Case report and literature review. Am J Clin Oncol 26 (2003) 531-534
66. Warakaulle D.R., Rytina E., and Burrows N.P. Merkel cell tumour associated with chronic lymphocytic leukaemia. Br J Dermatol 144 (2001) 216-217 (letter)
67. Ziprin P., Smith S., Salerno G., et al. Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukaemia. Br J Dermatol 142 (2000) 525-528
68. Pembroke A.C., Grice K., LeVantine A.V., et al. Eruptive angiomata in malignant disease. Clin Exp Dermatol 3 (1978) 147-156
69. Vergani R., Betti R., Uziel L., et al. Eruptive multiple sporadic cutaneous piloleiomyomas in a patient with chronic lymphocytic leukaemia. Br J Dermatol 143 (2000) 907-909 (letter)
70. Toner G.C., Holmes R., Kennedy J.T., et al. Lethal skin cancers in hairy cell leukemia (two case reports). Eur J Haematol 39 (1987) 82-85
71. Jacobs R.H., Vokes E.E., and Golomb M.H. Second malignancies in hairy cell leukemia. Cancer 56 (1985) 1462-1467
72. Schon M.P., Reifenberger J., Von Schmiedeberg S., et al. Multiple basal cell carcinomas associated with hairy cell leukaemia. Br J Dermatol 140 (1999) 150-153
73. Finan M.C., Sue W.P.D., and Li C.H. Cutaneous findings in hairy cell leukemia. J Am Acad Dermatol 11 (1984) 788-797
74. Jablonski K.P., Sterry W., Glokner W.M., et al. Multiple cutaneous malignancies and hairy cell leukemia. Z Hautkr 56 (1981) 1566-1571
75. Dinehart S.M., Anthony J.L., and Pollack S.V. Basal cell carcinoma in young patients after irradiation for childhood malignancy. Med Pediatr Oncol 19 (1991) 508-510
76. Garcia-Silva J., Velasco-Benito J.A., Pena-Penabad C., et al. Basal cell carcinoma in a girl after cobalt irradiation to the cranium for acute lymphoblastic leukemia: case report and literature review. Pediatr Dermatol 13 (1996) 54-57
77. Chang S.-E., Choi J.-H., Sung K.-J., et al. Multiple eruptive dermatofibromas occurring in a patient with acute myeloid leukaemia. Br J Dermatol 142 (2000) 1062-1063 (letter)
78. Kottaridis P.D., and Goldstone A.H. Development of squamous cell carcinoma of the skin during induction chemotherapy for acute myeloid leukemia. Leuk Lymphoma 43 (2002) 459-460 (letter)
79. Cervantes F., Rozman M., Guillermo A., et al. Neoplasias associadas a la leucemia mieloide chronica: incidencia en una serie de 288 pacientes. Med Clin (Barcelona) 91 (1988) 663-664
80. Alexandrescu D.T., and Wiernik P.H. Multiple eruptive dermatofibromas occurring in a patient with chronic myelogenous leukemia. Arch Dermatol 141 (2005) 397-398
81. Vey N., Camerlo J., Xerri L., et al. Simultaneous occurrence of Kaposi's sarcoma and chronic myelogenous leukaemia. Leuk Lymphoma 41 (2001) 425-428
82. Richert S., Bloom E.J., Flynn K., et al. Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature. J Am Acad Dermatol 35 (1996) 326-329
83. Angeli-Besson C., Koeppel M.C., Jacquet P., et al. Multiple squamous-cell carcinomas of the scalp and chronic myeloid leukemia. Dermatology 191 (1995) 321-322
84. Disdier P., Harle J.R., Grob J.J., et al. Rapid development of multiple squamous-cell carcinomas during chronic granulocytic leukemia. Dermatologica 183 (1991) 47-48
85. Stasi R., Cantonetti M., Abruzzese E., et al. Multiple skin tumors in long-term treatment with hydroxyurea. Eur J Haematol 48 (1992) 121-122
86. Papi M., Didona B., Depieta O., et al. Multiple skin tumors on light-exposed areas during long-term treatment with hydroxyurea. J Am Acad Dermatol 28 (1993) 485-486
87. Kahn H.S., Tatham L.M., Patel A.V., et al. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 280 (1998) 910-912
88. Frisch M., and Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 141 (1995) 916-922
89. Flindt-Hansen H., and Brandrup F. Malignant melanoma associated with mycosis fungoides. Dermatologica 169 (1984) 167-168
90. Soong W., Lee P.C., Kissel R.B., et al. Fatal malignant melanoma associated with a completely regressed primary melanoma in a patient with cutaneous T cell lymphoma. Arch Dermatol 123 (1987) 1270-1272
91. Elewski B.E., and Gilgor R.S. Eruptive lesions and malignancy. Int J Dermatol 24 (1985) 617-629
92. Green D.M., Hyland A., Barcos M.P., et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 18 (2000) 1492-1499
93. Castella A., Mason N., Clarke G., et al. Coexistence of malignant melanoma. Hodgkin's disease and follicular lymphoma with expression of the B-cell leukaemia/lymphoma (bcl-2) oncogene. Histopathology 35 (1999) 387-388 (letter)
94. Tucker M.A., Misferldt D., Coleman C.N., et al. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 102 (1985) 37-41
95. Tucker M.A., Coleman C.N., Rox R.S., et al. Tisk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318 (1988) 76-81
96. Swerdlow A.J., Barber J.A., Horwich A., et al. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 75 (1997) 116-123
97. Frisch M., Hjalgrim H., Olsen J.H., et al. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 125 (1996) 815-821
98. Levi F., La Vecchia C., Te V.C., et al. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 147 (1998) 722-726
99. Hialgrim H., Frisch M., Storm H.H., et al. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Int J Cancer 85 (2000) 639-642
100. Igisu K., Seki Y., Oka T., et al. Four primary malignant tumors including malignant melanomas and malignant lymphoma in the same patient. J Dermatol (Tokyo) 14 (1987) 170-174
101. Askling J., Sorensen P., Ekbom A., et al. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?. Ann Intern Med 131 (1999) 655-659
102. Cohen P.R. Basal cell carcinoma. J Greater Houston Dental Society 67 (1995) 20-21
103. Hampton T. Skin cancer's ranks rise: immunosuppression to blame. JAMA 294 (2005) 1476-1480
104. Wiernik P.H. Second neoplasms in patients with chronic lymphocytic leukemia. Cancer Treat Options Oncol 5 (2004) 215-223
105. Smoller B.R., and Warnke R.A. Cutaneous infiltrate of chronic lymphocytic leukemia and relationship to primary cutaneous epithelial neoplasm. J Cutan Pathol 25 (1998) 160-164
106. Garcia J.A., Cohen P.R., Herzberg A.J., et al. Pleomorphic basal cell carcinoma. J Am Acad Dermatol 32 (1995) 740-746
107. Tschen J.P., Cohen P.R., Schulze K.E., et al. Pleomorphic basal cell carcinoma: case reports and literature review. South Med J 99 (2006) 296-302
108. Cohen P.R., Schulze K.E., and Nelson B.R. Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision. South Med J 98 (2005) 740-747 (review)
109. Cohen P.R., Schulze K.E., and Nelson B.R. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg 32 (2006) 542-551
110. Chopra K.F., and Cohen P.R. Linear basal cell carcinomas: report of multiple sequential tumors localized to a radiotherapy port and review of the literature. Tex Med 93 (1997) 57-59
111. Cohen P.R. Multiple dermatofibromas in patients with autoimmune disorders receiving immunosuppressive therapy. Int J Dermatol 30 (1991) 266-270
112. Lu I., Cohen P.R., and Grossman M.E. Multiple dermatofibroma in a woman with HIV infection and systemic lupus erythematosus. J Am Acad Dermatol 32 (1995) 901-903